Mycoplasma pneumoniae

Last updated: September 12, 2024

Mycoplasma pneumoniae

Critical Care Week 2

Critical Care Week 2

Cardiovascular system anatomy and physiology
Coronary circulation
Abnormal heart sounds
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Atrial flutter
Atrial fibrillation
Supraventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Class III antiarrhythmics: Potassium channel blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Calcium channel blockers
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Atrial septal defect
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Anatomic and physiologic dead space
Ventricular arrhythmias: Pathology review
Wolff-Parkinson-White syndrome
Long QT syndrome and Torsade de pointes
Myocarditis
Adrenergic antagonists: Alpha blockers
Ventricular fibrillation
Pericardial disease: Pathology review
Action potentials in pacemaker cells
Cardiomyopathies: Clinical
Syncope: Clinical
Premature ventricular contraction
Heart failure: Clinical
Ventricular septal defect
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Pulmonary hypertension
Acute respiratory distress syndrome
Aortic aneurysms and dissections: Clinical
Peripheral vascular disease: Clinical
Valvular heart disease: Clinical
Pericardial disease: Clinical
Pulmonary embolism
Restrictive lung diseases
Pneumothorax
Chronic obstructive pulmonary disease (COPD): Clinical
Obstructive lung diseases: Pathology review
Chronic bronchitis
Coronary artery disease: Clinical
Diffuse parenchymal lung disease: Clinical
Restrictive lung diseases: Pathology review
Lung volumes and capacities
Compliance of lungs and chest wall
Gas exchange in the lungs, blood and tissues
Anatomy of the lungs and tracheobronchial tree
Pneumonia
Acute respiratory distress syndrome: Clinical
Respiratory alkalosis
Respiratory acidosis
Respiratory system anatomy and physiology
Pneumonia: Pathology review
Pneumonia: Clinical
Klebsiella pneumoniae
Chlamydia pneumoniae
Mycoplasma pneumoniae
Streptococcus pneumoniae
Pleural effusion: Clinical
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Imaging features of COVID-19 (LifeBridge Health)
Pseudomonas aeruginosa
Adenovirus
Asthma
Rheumatic heart disease
Deep vein thrombosis and pulmonary embolism: Pathology review
Cardiac conduction velocity
Cardiac tamponade
Cor pulmonale
Idiopathic pulmonary fibrosis
Diffusion-limited and perfusion-limited gas exchange
Ventilation-perfusion ratios and V/Q mismatch
Oxygen-hemoglobin dissociation curve
Oxygen binding capacity and oxygen content
Hypoxia
Pulmonary edema
Emphysema
Respiratory distress syndrome: Pathology review
Endocarditis
Angina pectoris
Stable angina
Unstable angina
Myocardial infarction
Prinzmetal angina
Peripheral artery disease
Aortic dissection
Aneurysms
Hypotension
Pulseless electrical activity
Mitral valve disease
Heart failure
Endocarditis: Pathology review
Infective endocarditis: Clinical
Restrictive cardiomyopathy
Valvular heart disease: Pathology review
Pulmonary valve disease
Aortic dissections and aneurysms: Pathology review
Saccular aneurysm
Atherosclerosis and arteriosclerosis: Pathology review
Marfan syndrome
Peripheral artery disease: Pathology review
Metabolic acidosis
Metabolic and respiratory acidosis: Clinical
Metabolic alkalosis
Metabolic and respiratory alkalosis: Clinical
Acid-base disturbances: Pathology review
Acid-base map and compensatory mechanisms
Upper respiratory tract infection
Clinical Skills: Respiratory rate assessment
Lung cancer: Clinical
Hypertension: Clinical
Class I antiarrhythmics: Sodium channel blockers
Regulation of pulmonary blood flow
Ventilation
Clinical Skills: Mechanical ventilation - conventional ventilators
Lung cancer
Standards of care for COVID-19 patients
Coronavirus disease 19 (COVID-19)
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Zones of pulmonary blood flow
Carbon dioxide transport in blood
Clinical Skills: BiPAP and CPAP
Bundle branch block
Adrenergic antagonists: Beta blockers

Transcript

Watch video only

Mycoplasma pneumoniae is a small bacterium which causes atypical pneumonia in young adults.

Mycoplasma, as a genus, have a cell membrane that is packed with sterols, but they lack a proper, rigid cell wall.

Therefore, they don’t take up dye under Gram staining, so they can’t be visualized with light microscopy.

Additionally, they are highly pleomorphic bacteria, meaning they have no fixed shape and size, and they’re also osmotically unstable in the external environment.

So, to survive, Mycoplasmas invade host cells and live intracellularly.

Now, Mycoplasma pneumoniae is a facultative anaerobe, meaning it can live without oxygen if it has to, but it grows better in an aerobic environment.

So it prefers places like lungs or respiratory airways, where there is an unlimited flow of oxygen.

As a result, some people may carry this bacteria in their nose or throat, and when they sneeze or cough, these organisms get out in the form of small respiratory droplets.

And when other people inhale these droplets, they may get infected, especially when they spend a lot of time together in close quarters.

So Mycoplasma pneumoniae infections occur mostly in children who go to school, young adults in college, or military recruits.

Following inhalation of the pathogen droplets, Mycoplasma pneumoniae attaches to an epithelial cell in the respiratory tract, using a specialized attachment organelle which has an adhesive protein complex, called ‘adhesion protein P1’ at its tip.

Adhesion protein P1 attaches to the host cell surface, like the respiratory epithelial cell, and holds on for dear life.

This makes it much harder for the mucociliary clearance mechanisms, which normally remove any foreign pathogen out of the respiratory tract, to clear the bacteria.

So Mycoplasma pneumoniae multiplies and damages the respiratory epithelial cells in the process.

When they reach the lungs, this starts a local inflammatory response, and lung tissue fills with white blood cells, proteins, fluid, and even red blood cells if a nearby capillary gets damaged in the process - leading to a local cytotoxic effect.

So Mycoplasma pneumoniae avoid the battlefield by sneaking inside lung cells, where they remain dormant or replicate intracellularly.

As a result, individuals infected by Mycoplasma pneumoniae are often asymptomatic or may have nonspecific symptoms like fatigue, sore throat, mild fever and dry hacking cough - all of which aren’t typical of bacterial pneumonia - hence the name atypical pneumonia.

Besides, the person may not feel very sick, as opposed to a person suffering from other bacterial pneumonia - where they’ll surely be bedridden and suffering from more severe symptoms like dyspnea, or shortness of breath, fever, chest pain, and a productive cough.

This is why, sometimes a case of atypical pneumonia is also referred to as walking pneumonia.

Mycoplasma pneumoniae can also cause encephalitis, especially following atypical pneumonia in children.

Key Takeaways

Mycoplasma pneumoniae is a type of bacteria that causes a type of pneumonia known as "walking pneumonia", because affected people may not feel very sick, as opposed to typical pneumonia. Mycoplasma pneumonia presents with milder symptoms, such as gradual onset of symptoms such as fever, cough, sore throat, and fatigue.